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Estimating Prion Adsorption Capacity of Soil by BioAssay
of Subtracted Infectivity from Complex Solutions
(BASICS)
A. Christy Wyckoff1,2, Krista L. Lockwood1, Crystal Meyerett-Reid1, Brady A. Michel1, Heather Bender1,
Kurt C. VerCauteren2, Mark D. Zabel1*
1 Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University Prion Research Center,
Fort Collins, Colorado, United States of America, 2 National Wildlife Research Center, Wildlife Services, United States Department of Agriculture, Fort Collins, Colorado,
United States of America

Abstract
Prions, the infectious agent of scrapie, chronic wasting disease and other transmissible spongiform encephalopathies, are
misfolded proteins that are highly stable and resistant to degradation. Prions are known to associate with clay and other soil
components, enhancing their persistence and surprisingly, transmissibility. Currently, few detection and quantification
methods exist for prions in soil, hindering an understanding of prion persistence and infectivity in the environment.
Variability in apparent infectious titers of prions when bound to soil has complicated attempts to quantify the binding
capacity of soil for prion infectivity. Here, we quantify the prion adsorption capacity of whole, sandy loam soil (SLS) typically
found in CWD endemic areas in Colorado; and purified montmorillonite clay (Mte), previously shown to bind prions, by
BioAssay of Subtracted Infectivity in Complex Solutions (BASICS). We incubated prion positive 10% brain homogenate from
terminally sick mice infected with the Rocky Mountain Lab strain of mouse-adapted prions (RML) with 10% SLS or Mte. After
24 hours samples were centrifuged five minutes at 2006g and soil-free supernatant was intracerebrally inoculated into
prion susceptible indicator mice. We used the number of days post inoculation to clinical disease to calculate the infectious
titer remaining in the supernatant, which we subtracted from the starting titer to determine the infectious prion binding
capacity of SLS and Mte. BASICS indicated SLS bound and removed $ 95% of infectivity. Mte bound and removed lethal
doses (99.98%) of prions from inocula, effectively preventing disease in the mice. Our data reveal significant prion-binding
capacity of soil and the utility of BASICS to estimate prion loads and investigate persistence and decomposition in the
environment. Additionally, since Mte successfully rescued the mice from prion disease, Mte might be used for remediation
and decontamination protocols.
Citation: Wyckoff AC, Lockwood KL, Meyerett-Reid C, Michel BA, Bender H, et al. (2013) Estimating Prion Adsorption Capacity of Soil by BioAssay of Subtracted
Infectivity from Complex Solutions (BASICS). PLoS ONE 8(3): e58630. doi:10.1371/journal.pone.0058630
Editor: Robert Shin Fujinami, University of Utah School of Medicine, United States of America
Received October 27, 2012; Accepted February 5, 2013; Published March 4, 2013
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for
any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Funding: United States Department of Agriculture Animal and Plant Health Inspection Services Cooperative Agreement number 08-7488-0680 (CA) funded this
work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: Mark Zabel serves as academic editor for PLOS ONE. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing
data and materials.
* E-mail: mark.zabel@colostate.edu

of prion-positive mortalities [5]. Once in the environment,
studies have shown PrPSc to adsorb strongly to soil components
[18–20], remain infectious [21–23] and persist for years
[5,7,21,24]. Indirect transmission most likely occurs through
incidental and geophagic ingestion of soil or other contaminated
fomites, as well as deer sign-post behavior such as scraping and
marking overhanging branches [5,8,25].
Experimental evidence suggests that the particularly strong
adsorption relationship of prions to soil colloids, or clays (defined
as particles ,4 mm), may be responsible for the longevity in the
environment [18,19]. Studies have shown percent-clay content of
soil significantly influences the cation exchange capacity of soil and
its overall negative charge [26]. Electrostatic and hydrophobic
interactions between the prion protein and clay are thought to
mediate this non-specific adsorption activity [27–30]. Specifically,
montmorillonite (Mte), the most commonly occurring smectite
clay, has been most implicated in the adsorption of prions in the

Introduction
Prions are infectious agents of transmissible spongiform
encephalopathies (TSEs) [1]. Misfolded, pathologic isoforms
(PrPSc) of the normal mammalian prion protein (PrPc) associate
with prion infectivity, generally resist protease degradation, and
often form insoluble, amyloidogenic aggregates [2]. Prions are
capable of horizontal transmission between animals and indirect
transmission from contaminated environments [3–10]. For
reasons that remain unclear, indirect environmental transmission
of prions appears to be limited to scrapie and chronic wasting
disease (CWD) prions, and does not appear to be an ecological
component of bovine spongiform encephalopathy (BSE) or other
TSEs. This phenomenon may relate to scrapie and CWD
sharing similar lymphotropic, shedding and transmission characteristics [11–13]. Infectious prions are likely deposited into the
environment through alimentary shedding [14,15], placental
material [16], antler velvet deposits [17] and the decomposition
PLOS ONE | www.plosone.org
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environment [31]. Mte is a 2:1 phyllosilicate clay consisting of 2
tetrahedral silica composed molecules flanking one octahedral
aluminum composed molecule, forming a sheet. An interlayer
space exists between sheets capable of expanding to .2 nm
depending on the cationic concentration of the solution. It has
been hypothesized that prions may enter this interlayer area like
other proteins. However, Johnson et al. [31] did not find evidence
of this in their experimental system and other studies suggest
extensive protein unfolding would be required [32], which is
unlikely for PrPSc. Mte is prevalent throughout the US mountain
west, including CWD endemic areas [33,34]. Models suggest that
the prevalence of Mte at a landscape level may explain and predict
CWD prevalence, which can exceed 20% in free-ranging cervids
[33,35].
Other soil components such as organic material, quartz, tannins
and humic acid have also been implicated in prion adsorption
[19,29,31,36–39]. Whole soil also includes highly reactive humic
substances, which have large specific surface areas and high
binding capacities [40]. Humic acid can coat mineral surfaces
imparting a net negative charge [41]. However, due to the
unknown tertiary structure of PrPSc, specific interactions and
adsorption dynamics to soil and humic substrates have yet to be
identified.
The robust adsorption relationship between the prion protein
and soil has proven difficult to measure or reverse, limiting
prion detection sensitivity, estimation of prion adsorption
capacity of soil [19,29,31,42] and general progress in studying
prions in the environment. Additionally, prion detection in soil
has been successful only in laboratory experiments using a
variety of different methods including antibody labeling [38],
electrophoresis [37], bioassay [22], detergent extraction [36] and
protein misfolding cyclic amplification (PMCA) [22,43].
To date, hypothesized soil interactions have largely been
demonstrated with recombinant prion proteins [27,29,36], which
probably interact differently with soil than glycosolated misfolded,
aggregated prions. Previous investigations of the soil-prion
relationship using whole brain homogenates containing mouse
and hamster adapted prions have attempted to quantify the
amount of PrPSc bound to soil [19,31,44]. But PrPSc does not
necessarily correlate with prion infectivity and studies estimating
infectivity using prion-bound soil fractions have produced
conflicting data. Soil-bound prions apparently increase infectivity
upon oral inoculation [22], but decrease infectivity upon
intracerebral (i.c.) inoculation [23]. To circumvent these issues,
and more accurately quantify infectious prion binding capacity of
soil, we developed a converse assay. We investigated the
adsorption capacity of prions to soil using an infectivity subtraction
assay of titrated prion strains. This methodology allows measurement of unbound and unadulterated prions instead of prions
bound to soil, which can alter infectivity [22,23]. We calculated
the adsorption capacity of two soil types, a whole Colorado sandy
loam soil (SLS) and pure montmorillonite clay (Mte) by assaying
residual infectivity of supernatants from prion-soil matrices using
TgA20 mouse bioassay [45]. SLS bound over 95% of prion
infectivity and Mte bound over 99.99% prion infectivity. These
data promote BASICS as an effective tool for quantifying prion
adsorption to soil as a function of infectivity and Mte as a potential
compound for bioremediation of prion-contaminated solutions.
We further propose that BASICS can improve estimates of
landscape contamination that might exist in scrapie or CWD
endemic areas, thereby enhancing our understanding of the larger
issues of environmental prion persistence.

PLOS ONE | www.plosone.org

Methods
Mice
TgA20 mice over-expressing mouse PrPc were generated as
previously described [45] and allowed for quantitative LD50
infectivity analysis [46–48], defined as the prion dose that kills half
of inoculated mice.

Ethics Statement
Mice were bred and maintained at Lab Animal Resources,
accredited by the Association for Assessment and Accreditation
of Lab Animal Care International, in accordance with protocols
approved by the Institutional Animal Care and Use Committee
at Colorado State University (Protocol ID: 09-1580A). Intracerebral inoculations were performed under Isoflurane anesthesia,
and mice euthanized using CO2 inhalation to effect followed by
decapitation. All efforts were made to minimize suffering.

Soil
Whole SLS used for this study was sourced from a private ranch
in Southern Colorado located on the eastern side of the Rocky
Mountains and within a game management unit which continues to
test negative for CWD in free-ranging cervid populations [49]. Soil
was collected with the land owner’s (A. C. Wyckoff) permission, no
additional permissions or permits were required for the described
field studies. SLS was passively air-dried, serially sifted first through
a 1 cm sieve to remove rocks and debris, then through a 2 mm sieve
and autoclaved (dry soil, 90 min at 120uC) to reduce incidental
biotic agents naturally present in soil. Montmorillonite (powdered
Western Bentonite) was sourced from Panther Creek, Co and
supplied by Ward’s Natural Science (San Luis Obispo, Ca).

Soil Analyses
Soil classification analysis of whole soil was conducted by the
Colorado State University Soil, Water and Plant Testing Laboratory (Fort Collins, Co). X-ray diffraction mineralogy analysis of
whole soil was conducted by K-T GeoServices, Inc. (Gunnison, Co).
Whole soil analysis included XRD weight percentage for bulk
(whole rock) and clay fraction (,4 mm), pH, percent organic
material, and soil texture classification of basic elements (Table 1).
The following definitions were used for clay mineral classification:
Mixed-Layer Illite/Smectite – A clay mineral group containing
interlayered or interstratified Illite and Smectite. Mixed layer type
was identified by the minerals involved (Illite and Smectite), the type
of order or stacking along the Z-axis (random or not ordered), and
the proportions of the minerals involved (10% Illite and 90%
Smectite). Illite and Mica – Common non-expanding minerals which
are hydrated silicates containing potassium, silica and aluminum.
Kaolinite and Chlorite – Common non-expanding hydrous aluminum
silicate clay minerals. Montmorillonite clay was not further
analyzed, specifics were obtained from the Material Safety Data
Sheet (MSDS) sheet provided by the supplier.

Sources and Preparation of Prion Inocula
The Rocky Mountain Lab passage 5 strain of mouse-adapted
scrapie (RML5) was previously described [50]. We derived the
TgA20RML strain by passaging RML5 into TgA20 mice,
resulting in inoculum with approximately one log lower
infectivity titer compared to the original RML5 (see Table 2).
Brain homogenates of clinically ill mice were prepared to 10%
dilution in PMCA buffer (4 mM EDTA, 150 nM NaCl in PBS)
and further diluted to 1% into similarly prepared 10% TgA20
normal brain homogenate (NBH) as previously described [51].
2

March 2013 | Volume 8 | Issue 3 | e58630

Estimating Prion Binding to Soil Using BASICS

brain homogenates (e.g. 30 mg dry soil added to 270 ml
homogenate). All inocula, with and without soil, were incubated
at 23uC for 24 hours on a rocker to balance maximal binding in a
competitive matrix with the decomposition of brain homogenate
[19,28,31]. Samples were then centrifuged for 5 min at 2006g
(Accuspin Micro, Fisher Scientific, Waltham, Ma) to clarify
solutions of soil particles, thereby subtracting prion infectivity
bound to soil or Mte from prion infectivity remaining in
supernatant. Inoculation groups included non-soil treated
TgA20RML and RML5 to establish baseline infectivity titers,
experimental treatments of TgA20RML and RML5 with SLS or
Mte soil, and a negative control of NBH with SLS.
Anesthetized mice were intracerebrally inoculated with 30 ml of
inoculum (with 1% Pen-Strep added) as previously described [51].
Each treatment groups consisted of 5–7 mice. Onset of clinical
disease was measured by scoring mice from normal (0) to
exhibiting terminal clinical signs (4) for 7 different clinical signs
including ataxia, akinesia, hyperactivity (0–3 scale), extensor
reflex, tail rigidity (0–2 scale), weight loss and tremors. Mice
receiving a composite score of 9 or greater, a single clinical score of
4, or exhibiting paralysis were euthanized and days post
inoculation (DPI) to clinical disease recorded. DPI was used to
calculate log infectivity titers of each inocula based on previous
LD50 determinations for RML in TgA20 mice [2,45,52]. We used
the linear equation y = 11.45–0.088x (y, logLD50 per gram of
brain; x, incubation time in DPI to terminal disease) to calculate
infectivity titers as outlined in Reed and Muench [48]. Several
non-clinical mice from each Mte-inoculated group were also
euthanized after 130 DPI, and 200 DPI (the end of the study) to
test their brain tissue for sub-clinical levels of prions by serial
protein misfolding cyclic amplification (sPMCA). Brains tissues
were collected from all mice for western blot (stored at 280uC)
and a subset of mouse brains were also sampled for histological
analysis (2/3 of brain was fixed in 10% formaldehyde, remaining
section was frozen). Statistical analysis of Kaplan-Meyer survival
curves and Student’s t-tests of log infectivity were conducted using
Prism 5 (GraphPad, La Jolla, Ca).

Table 1. Soil Component Analysis.
Whole Soila

Mineral
Quartz

35.9

K-Feldspar

9.3

Plagioclase

38.3

Amphibole

1.3

Calcite

1.3

Pyrite

1.6

Hematite

0.8

R0 M-L I/S 90Sb
Illite & Mica

Mtea

2.2 (19.1)c

b

100.0

7.7 (67.0)

Kaoliniteb

1.4 (12.2)

Chloriteb

0.2 (1.7)

Total

100.0 (11.5)d

100.0

Texture class

Sandy Loam

clay

% Sand

72.0

NAf

% Silt

14.0

NA

% Clay

14.0

100.0

Ph

7.5

9.9

EC (mmhos/cm)e

4.6

NA

% Organic Material

3.6

0

Soil Characteristics

a

% weight of whole SLS.
clay classification.
c
% of total clay weight.
d
clay weight % of total.
e
electrical conductivity (EC), measurement of salinity.
f
NA, not applicable.
doi:10.1371/journal.pone.0058630.t001
b

BioAssay of Subtracted Infectivity from Complex
Solutions (BASICS)
We performed an infectivity subtraction assay to estimate
binding capacity of SLS and Mte soil (Figure 1). We prepared 10%
w/vol soil solutions by adding dry soil to previously prepared 10%

sPMCA and Western Blotting
Brain tissues of clinical and non-clinical mice, as well as samples
of each inoculum were tested by western blotting before and after

Table 2. Incidence and infectivity titers of prion inocula before and after adsorption.

Inoculum

NBH
TgA20RML

RML5

Adsorbed to

SLS

Incidencea
(mean ± SD DPIb)

Infectivity Titerc

0/2 (non-clinical at 250)

% bound

Inputd

unbound

bound

0

0

0

0

NA

NA

e

nothing

4/4 (8263.4)

1.70

NA

SLS

6/6 (9966.4)

1.70

0.06

1.64

96.45

Mte

0/7 (non-clinical at 200)

1.70

0

1.70

100

nothing

4/4 (73613.5)

14.8

NA

NA

NA

SLS

7/7 (8766.6)

14.8

0.68

14.1

95.32

Mte

1/5 (109, 4 mice non-clinical at 200)

14.8

,0.0032f

$14.8

99.98

a

number of terminally ill mice/number infected.
DPI, days post infection.
c
6104 mean LD50 after 24 h @ 23uC. All SDs #0.0016104.
d
Initial titer of inocula prior to adsorption.
e
NA, not applicable.
f
below linear range of bioassay.
doi:10.1371/journal.pone.0058630.t002
b
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Figure 1. Visual Schematic of BASICS. To determine prion binding capacities of Mte and SLS, we incubated known titers of RML prions with or
without Mte or SLS for 24 h at 23uC. A brief, low-speed centrifugation separated bound prions in the pellet from unbound prions in the supernatant.
Degree of prion binding is then measured by bioassay in susceptible mice, subtracting supernatant titers from Mte (virtually no disease onset) or SLS
(long onset) bound samples from control RML (short onset) supernatant titers.
doi:10.1371/journal.pone.0058630.g001

transfer buffer (Invitrogen). Membranes were blocked for 1 hr
with 5% nonfat milk in PBS with 0.1% Tween 20, and incubated
overnight at 4uC in Superblock (Pierce, Waltham, Ma) with HRPconjugated anti-PrP Bar-224 monoclonal antibody (SPI bio)
diluted 1:20,000. Blots were washed 6610 min in PBS with
0.2% Tween 20 before visualizing proteins using Immobilon
chemiluminescent substrate (Millipore) and a Fujifilm LAS 3000
gel documentation system.

sPMCA. Prior to assay, brain tissues collected from mice were
homogenized following the methods of Meyerett et al. [51].
sPMCA amplification substrate consisted of 25 ml of 10% TgA20
NBH combined with 25 ml of sample in 0.2 ml tubes. Tubes were
sealed with parafilm, loaded into a holding tray and placed in a
37uC water bath in the Misonix 4000 sonicator horn (Qsonica
Inc., Farmingdale, NY). Samples were sonicated at approximately
200 watts (70% max power) for 40 sec every 30 min for 24 h,
constituting one round. For each subsequent round, 25 ml of each
sample from the previous round was added to 25 ml of fresh NBH.
Duplicates of each sample were subjected to 6 rounds of PMCA to
balance desired sensitivity (.80% of 1027 dilution prion samples
detected positive) and specificity (.98% of NBH samples remain
negative) of the detection assay. Each group of samples was
processed with at least five NBH negative controls and one positive
plate control (CWD positive elk brain homogenate E2, 1:10,000).
For visualization by western blot, 18 ml of sample was digested
with 2 ml of 50 mg/ml proteinase K (PK, Roche, Basel,
Switzerland) for 30 min at 45uC. The reaction was stopped by
adding lithium dodecyl sulfate sample loading buffer (Invitrogen,
Carlsbad, Ca) and boiling samples for 5 min at 95uC. Samples
were electrophoresed through 12% sodium dodecyl sulfate
polyacrylamide gels (Invitrogen) then electro-transferred to Immobilon PSQ PVDF membranes (Millipore, Billerica, Ma) in

PLOS ONE | www.plosone.org

Immunohistochemistry
Dissected tissues were prepared and stained for PrPSc detection
as previously described [51] with the following modifications.
Briefly, tissues were treated with DAKO target retrieval solutions
(DAKO, Carpinteria, Ca), then with formic acid to degrade PrPc.
PrPSc was labeled with anti-PrP BAR224 followed by incubation
with secondary EnVision HRP-conjugated anti-mouse antibody
that was visualized with chromagen 3-Amino-9-ethylcarbazole
(DAKO). Hemotoxylin and Glial fibrillary acidic protein (GFAP)
stain of activated astrocytes was performed by the Colorado State
University Histology and Diagnostic Laboratory as previously
described [51]. Briefly, slides were treated with DAKO target
retrieval solution then treated with primary anti-GFAP rabbit
antibody at 1:100 (Cell Marque, Rocklin, Ca). Secondary antirabbit-goat biotinillated antibody was used with (BioGenex, San
4
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Figure 2. Survival of TgA20 indicator mice following i.c. inoculations. (A) Kaplan-Meyer survival curve of 7 treatment groups demonstrates
the delayed disease onset in mice infected with SLS treated inocula (grey squares and triangles), and the nearly complete abrogation of disease in
mice infected with Mte treated inocula (open squares and triangles) compared to control mice infected with neat inocula (black squares and
triangles). Mice infected with SLS-treated negative brain homogenate (black dots) did not exhibit any disease. (B) Disease onset of each group were
clustered and consistent with reduced LD50 values. Inoculum type was significantly different (P,0.05) than their respective treatment, (* = significant
difference between TgA20RML treatments, w = significant differences between RML5 treatment groups). Data is presented with treatment group
median and s.d. error bars.
doi:10.1371/journal.pone.0058630.g002

imately 2% of total soil and 19.1% of total clay content in our
samples.
Incubation of 1% TgA20RML and 1% RML5 prions with
either SLS or Mte significantly reduced the bioassay infectivity,
resulting in delayed clinical disease (p,0.05, Figure 2 and Table 2).
Specifically, SLS incubation reduced the bioassay infectivity of the
TgA20RML by 28.2 fold, a 96.5% reduction in infectivity.
Infectivity of the same inoculum incubated with Mte was below
bioassay detection limits (130 DPI [46]), resulting in all mice
surviving to the end of the study at 200 DPI with no clinical signs
of disease. Likewise, the infectivity of the RML5 inoculum was

Romano, Ca) Enhanced Alkaline Phosphatase Red Detection Kit
(Ventana, Tucson, Az).

Results
In this study we collected soil from an area in southern
Colorado with similar soil composition to CWD endemic areas but
with no reported cases of CWD. Soil component analysis revealed
clay content similar to that found in areas of Colorado exhibiting
high prevalence (Table 1). Specifically, the smectite clay Mte,
previously shown to avidly bind prions [31] constituted approx-

PLOS ONE | www.plosone.org
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Figure 3. Representative PK digestion and Western blot
analyses of inocula and inoculated animals. All samples were
PK digested except lane 1 (A) PrPSc content of inocula were below
western blot detection levels with the exception of RML5 (lane 5). (B)
Brain homogenates from non-clinical experimental animals (lanes 8–9)
were also negative by western blot, however, samples from clinically ill
mice showed PrPSc (lanes 10–12). (C) With 6 rounds of PMCA, PrPSc was
detected in all inocula, and (D) in non-clinical mouse brain tissues
samples.
doi:10.1371/journal.pone.0058630.g003

reduced by 21.4 fold, or 95.3%, after incubation with SLS. The
mean binding capacity of SLS for RML prions in both inocula was
8.13610561.2 LD50 units/g soil. Incubation of RML5 with Mte
resulted in a near total removal of infectivity with only one mouse
becoming ill, equating to at least a 1380-fold reduction in
infectivity. Mte completely removed lethal doses of TgA20RML
prions (1.76104 LD50 units), indicating that its RML5 binding
capacity is at least 5.636108 LD50 units/g of Mte.
To determine whether non-clinically sick mice replicated subclinical levels of prions, we attempted to amplify minute quantities
of prions from their brains using sPMCA. We detected prions in
2/7 brains from non-clinical mice inoculated with TgA20RML
pre-adsorbed with Mte and 2/4 brains from non-clinical mice
inoculated with Mte-adsorbed RML (Figure 3, Table 3). These
results suggested that sub-clinical levels of prions existed in some
individuals despite the lack of clinical disease. To confirm this
observation, we also investigated neuropathology in these mice
and compared them to clinically ill mice. Histological examination
for PrPSc deposits, spongiosis and astrogliosis revealed differences
in histopathology between SLS-adsorbed prion-inoculated mice
and the single Mte-adsorbed RML5-inoculated mouse that
became clinically ill (Figure 4). We detected no PrPSc or
spongiform lesions and only mild astrogliosis in brains from nonclinical mice inoculated with control NBH (panels A and G) and
Mte-adsorbed TgA20RML (D and J). We detected small deposits
of PrPSc and spongiosis and slightly more astrogliosis in the brain
of the lone clinically sick mouse inoculated with Mte-adsorbed
RML5 (F and L). In contrast, we observed both diffuse and
punctate PrPSc aggregates and mild to severe spongiosis and
PLOS ONE | www.plosone.org

Figure 4. Representative Histology of TgA20 indicator mice.
Selected examples of histological analysis using immunohistochemistry
with PrP specific BAR224 Ab (reddish-brown staining, panels A–F) and
anti-GFAP antibody staining activated astrocytes (bright red, panels G–
L) in hippocampal sections. (A and G) Negative control sections from
mice inoculated with SLS-treated NBH exhibited no PrPSc staining or
spongiosis and limited astrocyte activation. (B and H) Positive control
sections from mice inoculated with RML5 revealed diffuse PrPSc staining
and significant spongiosis and astrogliosis. (C and I) Sections from mice
inoculated with SLS-treated TgA20RML resulted in limited PrPSc
deposits, spongiosis and astrogliosis, while (D and J) sections from
mice inoculated with Mte-treated TgA20RML revealed little or no
scrapie neuropathology. (E and K) sections from mice inoculated with
SLS-treated RML5 resulted in neuropathology similar to sections from
TgA20RML treated mice (Band H). (F and L) Hippocampal sections from
the only mouse to become ill with Mte treated RML5 showed limited
PrPSc spongiosis and astrogliosis.
doi:10.1371/journal.pone.0058630.g004
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route [23]. These factors potentially skewed estimates of infectious
doses adsorbed to soil.
BASICS circumvents these problems by quantifying prion
binding to soil by subtracting residual prion titers present after soil
adsorption from initial prion titers before soil adsorption. We are
currently titrating several other CWD field isolates and laboratory
strains and will use BASICS to quantify binding capacity of
relevant soil types to relevant prion strains.
We found a dramatic decrease in infectivity with a simple 24hour soil incubation. The Mte treatment of TgA20RML bound
sufficient amounts of infectious prions to prevent disease onset
entirely. Similar binding was seen in RML5 samples, resulting in
SLS binding 95.3% of infectious prions and the Mte binding
$99.98%. These results suggest that the adsorption capacity of the
Mte, in these experimental conditions, lies somewhere between the
TgA20RML and RML5 titers. If the Mte comprises the majority
of smectite clay in the soil (90% of the 2.2% smectite, Table 1),
then we calculate the maximal binding capacity of Mte present in
the soil to be 98.516104 LD50 units of RML per gram of soil. This
amount comprises between 2% and 18% of the total prion binding
capacity of soil that we observed for RML5 and TgA20RML,
respectively. The estimated 2% binding capacity of Mte for RML5
correlates to the 2% Mte found in SLS, suggesting that the Mte is
saturated with prion infectivity. The observation that the 2% of
Mte correlates to binding nine-fold more TgA20RML infectivity
(18% of total bound infectivity) in SLS also supports this
interpretation, because TgA20RML titers were approximately
nine times lower than RML5 titers. This would leave the
remaining prions available for binding to other soil components
such as other clays, quartz, humic acid or other organic material.
Indeed, other soil components have been implicated in protein
adsorption, including organic material, tannins, quartz
[19,29,31,36–39], and competitive matrices have been shown to
retard prion binding to soil [19]. Thus, we cannot completely
disqualify the effects of small amounts of residual soil components
remaining in solution after low-speed centrifugation that may bind
prions and decrease their infectivity upon i.c. inoculation. But
these effects are likely minor since centrifugation removed clay
components, which we show here as others have previously, to be
the major prion binders. If such effects exist, we again
acknowledge that BASICS would conservatively estimate prion
binding capacity of soil.
These data suggest that Mte is not the only factor determining
prion binding capacity of soil. However, we propose that prions
bind Mte with relatively high avidity and affinity compared to
other soil components, whose prion interaction may be more
reversible, creating equilibrium between prions bound to soil and
free in solution. We hypothesize that Mte concentrations in the soil
dictate this equilibrium and likely result in residual infectivity in
supernatants in our and other experimental systems [54,55] and
possibly increased mobility in a natural system [56]. Indeed, the
neuropathology and sPMCA data revealed sub-clinical levels of
prion in the brain tissue of mice inoculated with Mte-adsorbed
inoculum. Although the residual prions were not biologically
relevant since the mice exhibited no clinical or pathological signs
of scrapie, similar subclinical infections in wild cervid populations
may contribute to ecologically relevant contamination, persistence
and transmission.
Perhaps the most utilitarian finding of this study was the
prevention of disease by pre-adsorbing prions with Mte. These
data strongly promote Mte for prion remediation applications.
Environmental prion mitigation looms as a potential desideratum
for agriculture and wildlife management. However, options for
degradation and removal of prions have shown limited efficacy

Table 3. Disease status and detection of prions in non-clinical
mice inoculated with Mte-treated-inocula.

DPI

sPMCA +/2

1

131

+

2

131

2

3

131

2

4

200

+

5

200

2

6

200

2

7

200

2

1 (clinical)

109

+

2

131

2

3

131

2

4

200

+

5

200

+

Treatment Mice
TgA20RML-Mte

RML5-Mte

doi:10.1371/journal.pone.0058630.t003

astrogliosis in brains from clinically ill mice inoculated with nonadsorbed prions (B and H) and whole soil-adsorbed TgA20RML
(C and I) and RML (E and K). Together with the biochemical
analysis, these data confirm prion infection in clinically ill mice, as
well as sub-lethal infection in non-clinical mice, which we now call
sub-clinically ill mice.

Discussion
Environmental persistence and increased transmissibility of soil
bound prions remain poorly understood but extremely important
aspects of both scrapie and CWD ecology. The use of SLS and
Mte allowed us to model the complexity of prion binding in the
natural environment, while estimating the relative contribution of
a soil component previously shown to avidly bind prions. The use
of RML in these studies allowed for LD50 calculations and
quantitative statements of prion binding capacity of soil and Mte
as a function of infectivity. Use of whole brain homogenate, as
opposed to recombinant protein or enriched prions, accounts for
the complexity of the tissue and competitive matrix binding
activity [19]. PrPSc is conceivably a small component of the brain
matrix, and will compete with other proteins for binding sites on
soil particles. Previous studies revealed the potential for increased
adsorption if allowed to incubate for more than 24 hours [19], so
we consider the adsorption measurements in our study to be an
conservative estimate of the adsorption capacity of soil in a natural
system. However, as previously mentioned, we sought to balance
decomposition and microbial contamination of tissues with
binding activity. Surprisingly, we observed a nearly one log
reduction in infectivity of the positive control, non-adsorbed,
inocula simply from an 24-hour incubation at room temperature.
We also acknowledge that the behavior of RML in soil may not
fully represent the behavior of scrapie or CWD in soil [44,53]. We
used RML as a model system because RML titers have been
previously determined. Other recent prion-soil binding studies
used titered hamster scrapie strains to estimate [31] and quantify
[23] prion binding capacity of soil. However, both studies involved
inoculating soil bound prions, which exhibited different infectivity
than equivalent doses of unbound prions and varied by inoculation
PLOS ONE | www.plosone.org
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[57–59]. Our results suggest that the binding of prions to Mte may
be utilized for removing prions from liquids. Landscape application might not be feasible, but other decontamination or
remediation applications may be possible in the medical,
municipal and research sectors. For example, decontamination
of blood, urine and components thereof, as well raw water in
endemic areas and liquid waste in prion research facilities may be
feasible.
In summary, we propose that although constituting a relatively
small fraction of total soil, the high binding avidity and affinity of
Mte results in high prion occupancy at or near saturation that may
drive the likelihood of environmental prion contamination,
persistence and transmission in nature, as has been previously
suggested [33]. We are currently testing this hypothesis by
experimentally increasing Mte concentrations in whole soil and
using BASICS to assess the correlation to increased prion binding
capacity of soil.
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